跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,927 条关于
“AChR antibodies”
全部
3,927
临床试验
1,050
药物
411
机构
29
资讯
2,437
去年
Eculizumab Shows Promise in Treating Thymoma-Associated Myasthenia Gravis
去年
Ultomiris Shows Delayed but Significant Benefit in Generalized Myasthenia Gravis
去年
Zilbrysq Market Projected to Grow 21.64% Annually Through 2030 Following FDA Approval for Myasthenia Gravis
去年
VYVGART Achieves Primary Endpoint in Phase 3 Trial for AChR-Ab Seronegative Myasthenia Gravis
去年
Study Reveals Link Between AChR Antibody Levels and Myasthenia Gravis Treatment Response
9个月前
FDA Approves UPLIZNA as First CD19-Targeted B Cell Therapy for Generalized Myasthenia Gravis
10个月前
Johnson & Johnson Launches First Head-to-Head FcRn Blocker Study in Myasthenia Gravis
去年
Myasthenia Gravis Market Set to Reach $10.3 Billion by 2034 Driven by Seven Late-Stage Pipeline Therapies
去年
Alexion Secures Canadian Access Agreement for Ultomiris in Two Rare Autoimmune Diseases
2年前
CD137-Targeted Therapies Show Promise in Cancer Immunotherapy
第 1 页,共 244 页
上一页
下一页